Federal contract award

36C25222C0085

EKLUND CSRD GRANT TISSUE PATHOLOGY SECTIONING IDENTIFYING MOLECULAR MARKERS NORTHWESTERN

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Veterans Affairs
Office252-NETWORK CONTRACT OFFICE 12 (36C252)
NAICS541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSCAN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$0
Current contract value$0
Potential contract value / ceiling$0
Start dateSep 15, 2022
Current end dateSep 14, 2025
Potential end dateSep 14, 2025
Latest award activityAug 11, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 11, 2026P00004$-15.7KDE-OBLIGATE CONTRACT 36C25222C0085 BS YR PO 53722024, OP YR 1 537D32035, OP YR 2 537D42031 OP YR 3 NOT EXERCISED.
Aug 15, 2024P00002$5.4KEKLUND CSRD GRANT TISSUE PATHOLOGY SECTIONING IDENTIFYING MOLECULAR MARKERS NORTHWESTERN
Aug 1, 2023P00001$5.4KEKLUND CSRD GRANT TISSUE PATHOLOGY SECTIONING IDENTIFYING MOLECULAR MARKERS NORTHWESTERN
Aug 31, 20220$4.9KEKLUND CSRD GRANT TISSUE PATHOLOGY SECTIONING IDENTIFYING MOLECULAR MARKERS NORTHWESTERN

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.